The use of three-dimensional technologies in the development of oral solid dosage forms
DOI:
https://doi.org/10.24959/nphj.23.112Keywords:
three-dimensional printing; 3D printing; oral solid dosage forms; technologies; personalized medicineAbstract
Aim. To analyze the scientific literature data on the use of three-dimensional technologies in pharmacy, in particular in the technology of oral solid dosage forms, the advantages and disadvantages of 3D printing, and current research on the development of drugs using 3D printing.
Materials and methods. To achieve this goal, bibliosemantic and analytical methods were used.
Results and discussion. Personalized medicine is currently a major area of development in the healthcare sector. Its goal is to adapt treatment to a specific person, taking into account the peculiarities of the physiology, drug reactions, and the genetic profile. There are technologies that contribute to the paradigm shift from the traditional “one-size-fits-all”
approach to personalized medicine, the main one being three-dimensional (3D) printing. 3D printing involves the creation of a three-dimensional object using various computer programs. 3D printing can be used to create a wide range of dosage forms that differ in shape, release profile, and drug combination. The main 3D printing technology platforms under study in the pharmaceutical sector include inkjet printing, binder inkjet printing, fused filament manufacturing, selective laser sintering, stereolithography, and injection microsyringing.
Conclusions. The article discusses various 3D printing technologies and the prospects for their application in research on the development of new medicines, in particular oral solid dosage forms, and highlights their advantages and disadvantages.
References
Vaz V. M., Kumar L. 3D Printing as a Promising Tool in Personalized Medicine. AAPS PharmSciTech. 2021. Vol. 22. P. 1–20. DOI: 10.1208/s12249-020-01905-8.
A new chapter in pharmaceutical manufacturing: 3D-printed drug products / J. Norman et al. Advanced Drug Delivery Reviews. 2017. Vol. 108. P. 39-50. DOI: https://doi.org/10.1016/j.addr.2016.03.001.
Horst D. J. 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic Chemical Sciences. 2018. Vol. 1, № 2. Р. 1-4. DOI: 10.32474/AOICS.2018.01.000109.
Konta A. A., García-Piña M., Serrano D. R. Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful? Bioengineering. 2017. Vol. 4, № 79. P. 1-16. DOI: 10.3390/bioengineering4040079.
Zema L., Melocchi A., Maroni A., Gazzaniga A. Three-Dimensional Printing of Medicinal Products and the Challenge of Personalized Therapy. J. Pharm. Sci. 2017. Vol. 106. P. 1697–1705. DOI: 10.1016/j.xphs.2017.03.021.
An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems / K. Vithani et al. Pharm. Res. 2018. Vol. 36. P. 4. DOI: 10.1007/s11095-018-2531-1.
Emergence of 3D Printed Dosage Forms: Opportunities and Challenges / M. A. Alhnan et al. Pharmaceutical Research. 2016. Vol. 33. P. 1817–1832. DOI: 10.1007/s11095-016-1933-1.
Prasad L. K., Smyth H. 3D printing technologies for drug delivery: A review. Drug Development and Industrial Pharmacy. 2016. Vol. 42. P. 1019–31.
Samiei N. Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: A mini review. Beni-Suef Univ. J. Basic Appl. Sci. 2020. Vol. 9. P. 12. DOI: 10.1186/s43088-020-00040-4.
Siamidi A., Tsintavi E., Rekkas D. M., Vlachou M. 3D-Printed Modified-Release Tablets: A Review of the Recent Advances. Molecular Pharmacology. London, 2020. DOI: 10.5772/intechopen.90868.
Serrano D. R., Terres M. C., Lalatsa A. Applications of 3D printing in cancer. J. 3D Print. Med. 2018. Vol. 2. P. 115–127. DOI: 10.2217/3dp-2018-0007.
Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry? / S. M. Lamichhane et al. Asian J. Pharm. 2019. Vol. 14. P. 465–479. DOI: 10.1016/j.ajps.2018.11.008.
Technical Considerations for Additive Manufactured Medical Devices : Guidance for Industry and Food and Drug Administration Staff / Center for Devices and Radiological Health Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services. URL: https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM499809.pdf.
Abaci A., Gedeon C., Kuna A., Guvendiren M. Additive Manufacturing of Oral Tablets: Technologies, Materials and Printed Tablets. Pharmaceutics. 2021. Vol. 13 (2). P. 156. DOI: 10.3390/pharmaceutics13020156.
3D Printing Pharmaceuticals: Drug Development to Frontline Care / S. J. Trenfield et al. Trends Pharmacol. Sci. 2018. Vol. 39. P. 440–451. DOI: 10.1016/j.tips.2018.02.006.
Liang K., Brambilla D., Leroux J.-C. Is 3D Printing of Pharmaceuticals a Disruptor or Enabler? Adv. Mater. 2019. Vol. 31. P. 1805680. DOI: 10.1002/adma.201805680.
3D screen printing–An innovative technology for large-scale manufacturing of pharmaceutical dosage forms / D. Moldenhauer et al. Int. J. Pharm. 2020. Vol. 592. P. 120096. DOI: 10.1016/j.ijpharm.2020.120096.
Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms / J. R. Cerda et al. Pharmaceutics. 2020 Vol. 12. P. 345. DOI: 10.3390/pharmaceutics12040345.
Yu D. G., Zhu L.-M., Branford-White C. J., Yang X. L. Three-Dimensional Printing in Pharmaceutics: Promises and Problems. J. Pharm. Sci. 2008. Vol. 97. P. 3666–3690. DOI: 10.1002/jps.21284.
Oral dosage forms fabricated by Three Dimensional Printing™ / W. E. Katstra et al. J. Control. Release. 2000. Vol. 66. P. 1–9. DOI: 10.1016/S0168-3659(99)00225-4.
Jarosz P. J., Parrott E. L. Tensile Strengths and Hardness of Tablets. J. Pharm. Sci. 1982. Vol. 71. P. 705–707. DOI: 10.1002/jps.2600710625.
Shang C., Sinka I., Pan J. Modelling of the break force of tablets under diametrical compression. Int. J. Pharm. 2013. Vol. 445. P. 99–107. DOI: 10.1016/j.ijpharm.2013.01.032.
Pitt K. G., Heasley M. G. Determination of the tensile strength of elongated tablets. Powder Technol. 2013. Vol. 238. P. 169–175. DOI: 10.1016/j.powtec.2011.12.060.
Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling / R. Thakkar et al. Tool. Polymers. 2020. Vol. 12. P. 1872. DOI: 10.3390/polym12091872.
Zhang J., Thakkar R., Zhang Y., Maniruzzaman M. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach. Int. J. Pharm. 2020. Vol. 590. P. 119945. DOI: 10.1016/j.ijpharm.2020.119945.
Pharmaceutical applications of 3D printing technology: current understanding and future perspectives / B. J. Park et al. J. Pharm. Investig. 2019. Vol. 49. P. 575–585. URL: https://doi.org/10.1007/s40005-018-00414-y
Goyanes A., Buanz A. B., Basit A. W., Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 2014. Vol. 476. P. 88–92. DOI: 10.1016/j.ijpharm.2014.09.044.
Ziemian C., Crawn P. Computer aided decision support for fused deposition modeling. Rapid Prototyp. J. 2001. Vol. 7. P. 138–147. DOI: 10.1108/13552540110395538.
Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets / A. Goyanes et al. Int. J. Pharm. 2016. Vol. 514. P. 290–295. DOI: 10.1016/j.ijpharm.2016.06.021.
Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs / G. Kollamaram et al. Int. J. Pharm. 2018. Vol. 545. P. 144–152. DOI: 10.1016/j.ijpharm.2018.04.055.
Parulski C., Jennotte O., Lechanteur A., Evrard B. Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Adv. Drug Deliv. Rev. 2021. Vol. 175. P. 113810. DOI: 10.1016/j.addr.2021.05.020.
Skowyra J., Pietrzak K., Alhnan M. A. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur. J. Pharm. Sci. 2015. Vol. 68. P. 11–17. DOI: 10.1016/j.ejps.2014.11.009.
Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective / M. A. Azad et al. Pharmaceutics. 2020. Vol. 2. P. 1–34.
El Aita I., Breitkreutz J., Quodbach J. On-demand manufacturing of immediate release levetiracetam tablets using pressureassisted microsyringe printing. Eur J Pharm Biopharm. 2019. Vol. 134. P. 29–36. DOI: https://doi.org/10.1016/ j.ejpb.2018.11.008.
Scoutaris N., Ross S., Douroumis D. Current Trends on Medical and Pharmaceutical Applications of Inkjet Printing Technology. Pharm. Res. 2016. Vol. 33. P. 1799–1816. DOI: 10.1007/s11095-016-1931-3.
Trenfield S. J., Madla C. M., Basit A. W., Gaisford S. Binder jet printing in pharmaceutical manufacturing. AAPS Adv Pharm Sci Ser. 2018. Vol. 31. P. 41–54. doi: 10.1007/978-3-319-90755-0_3.
Binder jet 3D printing–Process parameters, materials, properties, modeling, and challenges / A. Mostafaei et al. Prog. Mater. Sci. 2021. Vol. 119. P. 100707. DOI: 10.1016/j.pmatsci.2020.100707.
Binder-jet 3D printing of indomethacin-laden pharmaceutical dosage forms / S. Y. Chang et al. J Pharm Sci. 2020. Vol. 109, № 10. P. 3054-3063. DOI: https://doi.org/10.1016/j.xphs.2020.06.027.
Wong K. V., Hernandez A. A Review of Additive Manufacturing. ISRN Mech. Eng. 2012. Vol. 2012. P. 1–10. DOI: 10.5402/2012/208760.
Wang J., Goyanes A., Gaisford S., Basit A. W. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. International Journal of Pharmaceutics. 2016. Vol. 503, № 1-2. P. 207–212. DOI: https://doi.org/10.1016/j.ijpharm.2016.03.016.
Analysis of in Vitro Dissolution of Whole vs. Half Controlled-Release Theophylline Tablets / V. P. Shah et al. Pharm. Res. 1987. Vol. 4. P. 416–419. DOI: 10.1023/A:1016442514205.
3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets / A. Goyanes et al. European Journal of Pharmaceutics and Biopharmaceutics. 2015. Vol. 89. P. 157–162. DOI: https://doi.org/10.1016/j.ejpb.2014.12.003.
Erramouspe J., Jarvi E. J. Effect on dissolution from halving methylphenidate extended-release tablets. Ann. Pharmacother. 1997. Vol. 31. P. 1123–1126. DOI: 10.1177/106002809703101001.
Lamichhane S., Park J.-B., Sohn D. H., Lee S. Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling. Pharmaceutics. 2019. Vol. 11. P. 564. DOI: 10.3390/pharmaceutics11110564.
An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems / K. Vithani et al. Pharm. Res. 2018. Vol. 36. P. 4. DOI: 10.1007/s11095-018-2531-1.
Formulation optimization of selective laser sintering 3D-printed tablets of clindamycin palmitate hydrochloride by response surface methodology / E. M. Mohamed et al. AAPS PharmSciTech. 2020. Vol. 21, № 6. P. 232. DOI: 10.1208/s12249-020-01775-0.
3D printing of tablets containing multiple drugs with defined release profiles / S. A. Khaled et al. Int J Pharm. 2015. Vol. 494, № 2. P. 643–650. DOI: https://doi.org/10.1016/j.ijpharm.2015.07.067.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
